Difficulty in treating older hepatitis C patients with combination ... (Hep C Treatment)

Difficulty in treating older hepatitis C patients with combination ...
EurekAlert (press release), DC - 10 hours ago... hepatology. Chronic hepatitis C virus (HCV), the most common cause of liver disease, affects approximately 300 million people worldwide. ...

(PRN) - Par Pharmaceutical's Partner Receives Final Approval to ...
Bolsamania.com, Spain - Dec 5, 2005... Rivers Pharmaceuticals Announces FDA Final Approval of Ribasphere(R) (ribavirin, USP) Tablets 600mg, 400mg and 200mg for the Treatment of Chronic Hepatitis C ...

FDA gives Fast Track status to Vertex s Hepatitis C treatment
Boston Mass High Tech, USA - Dec 8, 2005According to Vertex officials, the FDA granted the Fast Track designation because chronic hepatitis C virus infection is a serious and life-threatening disease ...

Viral Hepatitis Conference to Take Place February 27-28, 2006 in ...
PharmaLive.com (press release), PA - 19 hours ago5, 2006 /PRNewswire/ -- Chronic hepatitis C (HCV) and B (HBV) are the most common causes of chronic viral hepatitis in the United States, posing serious risks ...

Hepatitis C 'affecting thousands'
BBC News, UK - Dec 13, 2005Around 4,500 people in England and Wales are suffering from severe liver disease due to chronic hepatitis C infection, experts estimate. ...

Three Rivers Pharmaceuticals Announces FDA Final Approval of ...
Drug Newswire (press release), CT - Dec 5, 2005CRANBERRY TOWNSHIP, Pa. Three Rivers Pharmaceuticals, LLC today announced that the US Food and Drug Administration (FDA) has ...